Data managers and patients would benefit from an integrated, multidisciplinary approach to the informed consent process in clinical trials, according to a report in the December 1st issue of Cancer.
Previous studies indicate that patients remain insufficiently informed despite the adherence to strict informed consent policies, the authors explain, but little research has been done regarding the consent discussions between patients and data managers, those often charged with educating patients about the clinical trials process.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!